Given that LSD1 regulates ACE2–spike interactions, we next investigated whether LSD1 complexes with ACE2 in lymphocytes in COVID-19 patients, with the aim of providing novel insights into antiviral immunity in COVID-19. The gene discussed is ACE2; the disease is COVID-19.